South Africa Approves Groundbreaking HIV Prevention Drug Lenacapavir

In a landmark move hailed as a breakthrough in HIV prevention, the South African Health Products Regulatory Authority (SAHPRA) has approved the use of Lenacapavir, a long-acting injectable medicine that could transform the fight against HIV in the country. Lenacapavir, developed by Gilead Sciences, is […]